Project Grant T32GM154643

Award Date 7/1/25
Completion Date 6/30/30
Dollars Obligated $534K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Pensilvania, EE. UU.
Similar Awards
The University of Colorado Anschutz Medical Campus has been awarded a $340,192 Project Grant under the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859). The 5-year grant, effective July 11, 2025 through June 30, 2030, will provide funding for the university's Pharmacology and Molecular Medicine Training Program (PHARMM) to support 8 predoctoral students annually. The program aims to provide a highly interactive,...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $426,360 in funding to Case Western Reserve University (CWRU) from July 1, 2025 to June 30, 2030. The purpose of this award is to support the Molecular Pharmacology Training Program (MPTP), an interdisciplinary PhD program focused on developing innovative scientists with strong foundations in pharmacological principles and...
The National Institute of General Medical Sciences (NIGMS) has awarded a Project Grant (CFDA 93.859 - Biomedical Research and Research Training) totaling $331,270 to the Icahn School of Medicine at Mount Sinai (ISMMS) to support the Integrated Training in Pharmacological Sciences Program (ITPSP). The award, effective July 15, 2025 through June 30, 2030, aims to develop highly skilled biomedical scientists who will advance drug discovery through rigorous and ethical research, leveraging...
This federal Project Grant award of $426,360 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will support the Yale Predoctoral Pharmacology Training Program (PPTP) from July 1, 2025 to June 30, 2030. The PPTP aims to train an outstanding and diverse group of graduate students in the pharmacological sciences for research careers in academia, the pharmaceutical/biotechnology industries, or government. The...
The National Institute of General Medical Sciences (NIGMS) awarded a $268,725 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Purdue University. The grant, titled "Purdue Drug Discovery Training Program," aims to provide predoctoral students with cross-disciplinary training at the chemical-biology interface pertaining to drug discovery. The program's objective is to equip trainees with a comprehensive skill set, exposure to the drug...
The National Institute of General Medical Sciences (NIGMS) awarded a $103,158 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Regents of the University of Minnesota, doing business as the Office of Sponsored Projects Administration. The grant will fund the Molecular Pharmacology and Therapeutics (MPAT) graduate program at the University of Minnesota over a 5-year period from July 2025 to June 2030. The key objectives of this grant are to transform...
The National Institute of General Medical Sciences (NIGMS) awarded a $752,456 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Pittsburgh. The grant, effective September 1, 2024 through July 31, 2029, supports the development and application of innovative, user-friendly computational technologies for identifying new bioactive small molecules and improving their pharmacological properties. Key focus areas include creating a database of...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $534,450 in funding to The Trustees of the University of Pennsylvania to support the Predoctoral Training Program in Genetics (GEN-TG) at the Perelman School of Medicine. The primary goal of the GEN-TG is to recruit, train, and mentor outstanding individuals who will become future leaders in genetic research, effective educators, and...
This $767,525 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) aims to harness the potential of radical-mediated migrations to develop new synthetic transformations for pharmaceutical development. The grant supports research by The Pennsylvania State University to make significant advances in olefin difunctionalizations and stereoselective α-functionalizations of carbonyls. These...
This $166,192 Project Grant was awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training (CFDA 93.859) program to the Seattle Children's Research Institute. The grant will fund a training program focused on the clinical pharmacology of biotherapeutics, with the goal of educating the next generation of physician-scientists to become global leaders in this field. The program will provide postdoctoral clinicians from over 25...

This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under CFDA Program 93.859 Biomedical Research and Research Training, provides $534,450 in funding to the University of Pennsylvania to support a 5-year Predoctoral Training Program in Pharmacology. The program aims to prepare graduate students for productive careers in disciplines requiring fundamental knowledge of quantitative and systems pharmacology. Key program elements include coursework in pharmacology, cell/molecular biology, and statistics, as well as hands-on research training, seminars, and professional development activities. The program will support up to 12 predoctoral trainees per year, with trainees receiving funding for their second and third years of graduate school. The award period runs from July 1, 2025 to June 30, 2030.

Generated 8/5/25, 6:12 AM